Dagmar Koethe
Affiliations: | 2001-2006 | Department of Psychiatry and Psychotherapy | University of Cologne, Köln, Nordrhein-Westfalen, Germany |
Google:
"Dagmar Koethe"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Couttas TA, Boost C, Pahlisch F, et al. (2024) Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers. Bmj Mental Health. 27 |
Jieu B, Sykorova EB, Rohleder C, et al. (2024) Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol. Psychiatry Research. 339: 116005 |
Hickie IB, Iorfino F, Rohleder C, et al. (2023) EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disorders. Bmj Open. 13: e072082 |
Koethe D, Rohleder C, Kracht L, et al. (2023) Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state. Frontiers in Psychiatry. 14: 1088459 |
Carpenter JS, Zmicerevska N, Crouse JJ, et al. (2022) Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial. Bmj Open. 12: e056298 |
Couttas TA, Boost C, Pahlisch F, et al. (2022) Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and -Acylethanolamines by Liquid Chromatography-Tandem Mass Spectrometry. Cannabis and Cannabinoid Research |
Nichles A, Zmicerevska N, Song YJC, et al. (2021) Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention service. Bmj Open. 11: e044731 |
Leweke FM, Rohleder C, Gerth CW, et al. (2021) Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial. Frontiers in Pharmacology. 12: 614811 |
Bien CG, Rohleder C, Mueller JK, et al. (2021) Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers. Frontiers in Psychiatry. 12: 654602 |
Woelfl T, Rohleder C, Mueller JK, et al. (2020) Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers. Frontiers in Psychiatry. 11: 576877 |